Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tesaro, Inc.

Clinical trials sponsored by Tesaro, Inc., explained in plain language.

Now part of GSK plc GSK NYSE

Oncology biotech acquired by GSK, known for cancer drug Zejula.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 5 Completed 1 Terminated 1

New drug cocktails tested for advanced cancers: hope or hype?

Disease control Completed

This early-phase trial tested several combinations of cancer drugs, including niraparib, TSR-042, bevacizumab, and various chemotherapies, in 60 patients with advanced or metastatic cancer. The main goal was to find safe doses for future studies. The trial has been completed, but…

Phase: PHASE1 • Sponsor: Tesaro, Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:59 UTC